Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life?
舊有與新型抗糖尿病藥物的胃腸道不良反應:我們在現實生活中如何應對?
Rev Gastroenterol Mex (Engl Ed) 2024-10-25
Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6.
GLP-1受體激動劑與二甲双胍聯合使用時出現胃腸不良事件的發生:LEADER、STEP 2、SUSTAIN-6和PIONEER 6的事後分析。
Diabetes Care 2024-02-04
Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort.
葡萄糖樣肽-1 受體激動劑相關的胃腸不良事件:美國國家衛生研究院「All of Us」群體的橫斷面分析。
Pharmaceuticals (Basel) 2024-02-27
Gastrointestinal safety evaluation of semaglutide for the treatment of type 2 diabetes mellitus: A meta-analysis.
Semaglutide治療2型糖尿病的胃腸安全性評估:一項荟萃分析。
Medicine (Baltimore) 2024-05-24
Metformin: Diverse molecular mechanisms, gastrointestinal effects and overcoming intolerance in type 2 Diabetes Mellitus: A review.
Metformin:多樣的分子機制、腸胃道影響及克服2型糖尿病不耐受的策略:一篇綜述。
Medicine (Baltimore) 2024-10-29
Risk factor screening and prediction modeling of gastrointestinal adverse reactions caused by GLP-1RAs.
GLP-1RAs 引起的胃腸不良反應的風險因素篩查與預測模型。
Front Endocrinol (Lausanne) 2024-12-24
Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database.
美國 GLP-1 受體激動劑的胃腸安全性評估:來自 FAERS 數據庫的真實世界不良事件分析。
Diagnostics (Basel) 2025-01-08
Gastrointestinal adverse events associated with GLP-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis.
與 GLP-1 受體激動劑相關的腸胃不良事件在代謝功能障礙相關脂肪肝病 (MASLD) 中的系統性回顧與統合分析。
Front Med (Lausanne) 2025-03-07